Stay updated on Nivolumab Ipilimumab in CKS Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab in CKS Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study page now includes sponsor and collaborating institution details (Alona Zer and Rabin Medical Center) and updates metadata with Last Verified and a new Revision: v3.6.0. New help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment label formatting was standardized.SummaryDifference2%

- Check19 days agoChange DetectedThe bottom revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page content.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4. This reflects a new version of the study record published for the page, likely due to minor editorial or QC updates.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s footer revision/version label was updated from v3.5.2 to v3.5.3, indicating a site release without any change to the trial’s displayed study details.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check98 days agoChange DetectedFooter revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab in CKS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.